Absci ABSI
NASDAQ ABSI
$8.82 +0.02 (+0.23%)
As of: Sep 4, 2026 · 3:59 PM EDT

Absci (ABSI) Capital Expenditures (2020 - 2026)

Absci (ABSI) posted Capital Expenditures of $30000.0 for Q1 2026, up 129.13% sequentially from -$103000.0 in Q4 2025, and up 20.0% YoY from $25000.0 in Q1 2025.

Analysis

Absci (ABSI) Capital Expenditures (2020 - 2026) Analysis & Trends

Absci has reported Capital Expenditures for 7 years, with the latest figure at $30000.0 in Q1 2026.

  • Quarterly Capital Expenditures rose 20.0% year-over-year to $30000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 159.21% YoY) and the FY2025 annual result came in at $1.1 million, up 174.01% from the prior year.
  • Capital Expenditures grew to $30000.0 in Q1 2026 per ABSI's latest filing, from -$103000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $13.6 million in Q3 2022 and troughed at -$15.6 million in Q4 2022.
  • A 5-year average of $101866.7 and a median of $30000.0 in 2026 frame the typical range for Capital Expenditures.
  • The widest YoY moves for Capital Expenditures: up 10356.25% in 2022, down 321.69% in 2022.
  • Over 5 years, Capital Expenditures stood at -$15.6 million in 2022, then surged by 99.5% to -$78000.0 in 2023, then jumped by 525.64% to $332000.0 in 2024, then plunged by 131.02% to -$103000.0 in 2025, then soared by 129.13% to $30000.0 in 2026.
  • According to Business Quant data, Capital Expenditures over the past three periods registered $30000.0, -$103000.0, and $962000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 112.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 240.20 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 37.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 2.29 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 25.02 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 34.68 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 251.02 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.26 Mn
10 Absci 1.39 Bn 1.19 Bn - 1,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1,000.00
Mar 31, 2026 30,000.00
Dec 31, 2025 -103,000.00
Sep 30, 2025 962,000.00
Jun 30, 2025 223,000.00
Mar 31, 2025 25,000.00
Dec 31, 2024 159,000.00
Sep 30, 2024 48,000.00
Jun 30, 2024 337,000.00
Mar 31, 2024 -4,000.00
Dec 31, 2023 17,000.00
Sep 30, 2023 307,000.00
Jun 30, 2023 256,000.00
Mar 31, 2023 280,000.00
Dec 31, 2022 560,000.00
Sep 30, 2022 4.87 Mn
Jun 30, 2022 3.89 Mn
Mar 31, 2022 6.86 Mn
Dec 31, 2021 8.32 Mn
Sep 30, 2021 5.62 Mn